CD8A and neoplasm: Consistently, treatment with CTS/p(I:C)‐MMA was more efficient than free CTS/p(I:C) in decreasing the levels of tumor‐infiltrating M2‐TAMs and recruiting CD8+ T cells (Figure S14c,d, Supporting Information).